FDA Authorizes Novavax COVID Vaccine for Adults

Published on : Published by : BioBuzz Media

FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year
PUBLISHED WED, JUL 13 20224:24 PM EDTUPDATED WED, JUL 13 20224:48 PM EDT
Spencer Kimball
@SPENCEKIMBALL
SHARE
Share Article via Facebook
Share Article via Twitter
Share Article via LinkedIn
Share Article via Email
KEY POINTS
FDA authorization of Novavax’s vaccine was delayed for weeks as the agency reviewed changes to the company’s manufacturing process.
The Novavax shot is based on more conventional protein technology used for decades in hepatitis B and HPV vaccines, while Pfizer and Moderna are the first FDA approved vaccines to use mRNA.
Novavax was one of the original participants in the U.S. government’s race to develop a Covid vaccine in 2020, receiving $1.8 billion in taxpayer funding from Operation Warp Speed.
In this article
NVAX
-4.20 (-6.00%)
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials.
Pavlo Gonchar | LightRocket | Getty Images
The Food and Drug Administration has authorized Novavax’s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. since the pandemic began.
The…

The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines

Published on : Published by : Alex Keown

Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role in producing several COVID-19 Vaccines.  However, the history of this facility goes back more than two decades.

Rockefeller Foundation Grant Aims to Boost Vaccinations Among African American Communities

Published on : Published by : Alex Keown

Fueled by a $400,000 grant from The Rockefeller Foundation, the Black Women’s Health Imperative (BWHI), based in Washington, D.C., aims to improve vaccination rates among the African-American community through outreach programs and strategic partnerships with like-minded coalitions, including the National Caucus & Center on Black Aging (NCBA) and National Coalition of 100 Black Women (NCBW).

Novavax Starting Summer of 2021 with Positive COVID-19 Vaccine Data and a Visit from Governor Hogan

Published on : Published by : Andy Eckert

With a visit from Maryland Governor Larry Hogan at the location of their future Vaccines Innovation Campus and Global Headquarters In Gaithersburg, positive data on their COVID-19 Variant Strain Vaccine, and a Phase 3 Trial showing 90% Overall Efficacy/100% Protection Against Moderate and Severe Disease in PREVENT-19. Novavax had one of the most newsworthy weeks to kick off the Summer of 2021.

Novavax Vaccine Could Generate $33 Billion in Revenue through 2027, Analyst Says

Published on : Published by : Alex Keown

Novavax is aiming to seek Emergency Use Authorization for its COVID-19 vaccine NVX-CoV2373 later this spring. If the U.S. Food and Drug Administration gives it the green light, the Maryland-based company could see revenue of approximately $1.8 billion in sales by the end of the year.

In Conversation: Dr. Vipin K. Garg, CEO of Altimmune

Published on : Published by : Steven Surdez

Dr. Vipin Garg, Altimmune’s (ALT) CEO since 2018 and a biotech industry veteran, has successfully led the publicly-traded company through these turbulent pandemic waters. We recently caught up with Dr. Garg to discuss the pandemic, Altimmune’s deep product pipeline, his unique perspectives on the BioHealth Capital Region (BHCR), and the state of the U.S. supply chain and biotech manufacturing ecosystem.

What Employers Should Know About Vaccination Requirements, Screenings and Return to Work Plans

Published on : Published by : Alex Keown

More than 100 million doses of COVID-19 vaccines have been administered in the United States and many companies are hoping this will signal a significant return to work for most employees. But, before that happens, there may be pending legal questions about vaccination requirements ahead.